Serological Evaluation of Soluble CD44 in Renal Cancer

In this study, we examined the feasibility of using elevated serum CD44 concentration as an indicator in renal cancer. We performed enzyme‐linked immunosorbent assays using 63 sera obtained from 47 patients with renal cancer and 16 healthy controls and evaluated the clinico‐pathological parameters....

Descripción completa

Detalles Bibliográficos
Autores principales: Kan, Masaharu, Kanayama, Hiro‐omi, Naruo, Seiichi, Tsuji, Masahito, Kojima, Keiji, Kurokawa, Yasushi, Kagawa, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1996
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921015/
https://www.ncbi.nlm.nih.gov/pubmed/9045950
http://dx.doi.org/10.1111/j.1349-7006.1996.tb03131.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921015/
https://www.ncbi.nlm.nih.gov/pubmed/9045950
http://dx.doi.org/10.1111/j.1349-7006.1996.tb03131.x

Ejemplares similares